Endocrinology, Vol 135, 1934-1944, Copyright © 1994 by Endocrine Society

ARTICLES

Effects of selective type I and II adrenal steroid agonists on immune cell distribution

AH Miller, RL Spencer, J hassett, C Kim, R Rhee, D Ciurea, F Dhabhar, B McEwen and M Stein
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029.

Adrenal steroids exert their effects through two distinct adrenal steroid receptor subtypes; the high affinity type I, or mineralocorticoid, receptor and the lower affinity type II, or glucocorticoid, receptor. Adrenal steroids have well known effects on immune cell distribution, and although both type I and II receptors are expressed in immune cells and tissues, few data exist on the relative effects mediated through these two receptor subtypes. Accordingly, we administered selective type I and II adrenal steroid receptor agonists to young adult male Sprague-Dawley rats for 7 days and then measured immune cell distribution in the peripheral blood and spleen. Results were compared with those of similar studies using the naturally occurring glucocorticoid of the rat, corticosterone, which binds both type I and II receptors. The majority of the well characterized effects of adrenal steroids on peripheral blood immune cells (increased neutrophils and decreased lymphocytes and monocytes) were reproduced by the type II receptor agonist, RU28362. RU28362 decreased the numbers of all lymphocyte subsets [T-cells, B-cells, and natural killer (NK) cells] to very low absolute levels. The largest relative decrease (i.e. in percentage) was seen in B-cells, whereas NK cells exhibited the least relative decrease and actually showed a 2-fold increase in relative percentage during RU28362 treatment. Similar to RU28362, the type I receptor agonist, aldosterone, significantly reduced the number of lymphocytes and monocytes. In contrast to RU28362, however, aldosterone significantly decreased the number of neutrophils. Moreover, aldosterone decreased the number of T-helper cells and NK cells, while having no effect on the number of B-cells or T- suppressor/cytotoxic cells. Corticosterone at physiologically relevant concentrations had potent effects on immune cell distribution, which were indistinguishable from those of the type II receptor agonist, RU28362. Taken together, these results indicate that effects of adrenal steroids on immune cell distribution are dependent on the receptor subtype involved as well as the specific cell type targeted. These factors allow for varied and complex effects of adrenal steroids on the immune system under physiological conditions.

This article has been cited by other articles:

				S. Kern and T. Ziemssen Review: Brain immune communication psychoneuroimmunology of multiple sclerosis Multiple Sclerosis, January 1, 2008; 14(1): 6 - 21. [Abstract] [PDF]

				S. A. Madsen-Bouterse, G. J. M. Rosa, and J. L. Burton Glucocorticoid Modulation of Bcl-2 Family Members A1 and Bak during Delayed Spontaneous Apoptosis of Bovine Blood Neutrophils Endocrinology, August 1, 2006; 147(8): 3826 - 3834. [Abstract] [Full Text] [PDF]

				K. Viswanathan and F. S. Dhabhar Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation PNAS, April 19, 2005; 102(16): 5808 - 5813. [Abstract] [Full Text] [PDF]

				C. L. Schwab, R. Fan, Q. Zheng, L. P. Myers, P. Hebert, and S. B. Pruett Modeling and Predicting Stress-Induced Immunosuppression in Mice Using Blood Parameters Toxicol. Sci., January 1, 2005; 83(1): 101 - 113. [Abstract] [Full Text] [PDF]

				P. Sterzer, G. J. Wiegers, and J. M. H. M. Reul Long-Term in Vivo Administration of Glucocorticoid Hormones Attenuates Their Capacity to Accelerate in Vitro Proliferation of Rat Splenic T Cells Endocrinology, August 1, 2004; 145(8): 3630 - 3638. [Abstract] [Full Text] [PDF]

				P. S. D. Weber, T. Toelboell, L.-C. Chang, J. D. Tirrell, P. M. Saama, G. W. Smith, and J. L. Burton Mechanisms of glucocorticoid-induced down-regulation of neutrophil L-selectin in cattle: evidence for effects at the gene-expression level and primarily on blood neutrophils J. Leukoc. Biol., May 1, 2004; 75(5): 815 - 827. [Abstract] [Full Text] [PDF]

				F. S. Dhabhar A Hassle a Day May Keep the Doctor Away: Stress and the Augmentation of Immune Function Integr. Comp. Biol., July 1, 2002; 42(3): 556 - 564. [Abstract] [Full Text] [PDF]

				R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text]

				J. Daigle and D. J. J. Carr Androstenediol Antagonizes Herpes Simplex Virus Type 1-Induced Encephalitis Through the Augmentation of Type I IFN Production J. Immunol., March 15, 1998; 160(6): 3060 - 3066. [Abstract] [Full Text] [PDF]

				B. S. McEwen Protective and Damaging Effects of Stress Mediators N. Engl. J. Med., January 15, 1998; 338(3): 171 - 179. [Full Text] [PDF]

				N. Shanks, R. J. Windle, P. A. Perks, M. S. Harbuz, D. S. Jessop, C. D. Ingram, and S. L. Lightman Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation PNAS, May 9, 2000; 97(10): 5645 - 5650. [Abstract] [Full Text] [PDF]